Table 2B. Results of joinpoint regression analysis on the trends in site-specific cancer incidence: data from three prefectures (1985–2015); Femalea.
Cancer site | ICD-10 | Number of joinpoints |
Line segment | Annual % change |
95% confidence interval |
||||
Start | End | Lower | Upper | ||||||
Major | |||||||||
Stomach | C16 | 1 | 1985 | 2003 | −2.6 | −3.0 | −2.2 | * | |
2003 | 2015 | −1.2 | −2.0 | −0.4 | * | ||||
Colon | C18 | 1 | 1985 | 1995 | 3.6 | 2.6 | 4.6 | * | |
1995 | 2015 | 0.5 | 0.2 | 0.8 | * | ||||
Rectum | C19–C20 | 2 | 1985 | 1999 | 1.9 | 1.5 | 2.3 | * | |
1999 | 2004 | −3.2 | −5.5 | −0.7 | * | ||||
2004 | 2015 | 1.4 | 0.9 | 2.0 | * | ||||
Colon/rectum | C18–C20 | 2 | 1985 | 1996 | 3.2 | 2.6 | 3.7 | * | |
1996 | 2003 | −0.7 | −1.8 | 0.4 | |||||
2003 | 2015 | 0.9 | 0.5 | 1.3 | * | ||||
Liver | C22 | 2 | 1985 | 1995 | 2.8 | 1.4 | 4.2 | * | |
1995 | 2010 | −1.2 | −1.9 | −0.4 | * | ||||
2010 | 2015 | −8.5 | −12.2 | −4.7 | * | ||||
Pancreas | C25 | 0 | 1985 | 2015 | 1.3 | 1.0 | 1.6 | * | |
Lung, trachea | C33–C34 | 0 | 1985 | 2015 | 1.9 | 1.6 | 2.1 | * | |
Breast | C50 | 1 | 1985 | 2010 | 4.0 | 3.8 | 4.2 | * | |
2010 | 2015 | 1.7 | −0.2 | 3.6 | |||||
Uterus | C53–C55 | 1 | 1985 | 1991 | −4.6 | −7.8 | −1.4 | * | |
1991 | 2015 | 2.8 | 2.3 | 3.2 | * | ||||
Cervix uteri | C53 | 1 | 1985 | 1991 | −5.3 | −9.8 | −0.6 | * | |
1991 | 2015 | 1.3 | 0.7 | 2.0 | * | ||||
Corpus uteri | C54 | 0 | 1985 | 2015 | 5.0 | 4.5 | 5.4 | * | |
Sub-major | |||||||||
Esophagus | C15 | 1 | 1985 | 1996 | −2.8 | −5.3 | −0.1 | * | |
1996 | 2015 | 2.1 | 0.9 | 3.2 | * | ||||
Gallbladder and bile ducts | C23–C24 | 1 | 1985 | 1997 | −1.1 | −2.0 | −0.2 | * | |
1997 | 2015 | −3.0 | −3.5 | −2.5 | * | ||||
Ovary | C56 | 0 | 1985 | 2015 | 1.8 | 1.4 | 2.1 | * | |
Urinary bladder | C67 | 0 | 1985 | 2015 | −0.6 | −1.1 | 0.0 | * | |
Kidney and other urinary organs (except bladder) | C64–C66 C68 | 0 | 1985 | 2015 | 2.9 | 2.5 | 3.3 | * | |
Thyroid | C73 | 3 | 1985 | 1991 | 10.3 | 5.5 | 15.4 | * | |
1991 | 2002 | −0.5 | −2.3 | 1.4 | |||||
2002 | 2008 | 6.5 | 1.4 | 11.8 | * | ||||
2008 | 2015 | −1.2 | −3.9 | 1.7 | |||||
Malignant lymphoma | C81–C85 C96 | 0 | 1985 | 2015 | 3.7 | 3.4 | 4.1 | * | |
Others | |||||||||
Oral cavity and pharynx | C00–C14 | 0 | 1985 | 2015 | 2.2 | 1.5 | 2.8 | * | |
Larynx | C32 | 0 | 1985 | 2015 | 0.6 | −1.3 | 2.7 | ||
Skin | C43–C44 | 2 | 1985 | 1997 | −1.3 | −2.6 | 0.0 | ||
1997 | 2003 | 6.9 | 2.1 | 11.8 | * | ||||
2003 | 2015 | 1.9 | 0.9 | 3.0 | * | ||||
Brain, nervous system | C70–C72 | 0 | 1985 | 2015 | −0.6 | −1.4 | 0.1 | ||
Multiple myeloma | C88–C90 | 0 | 1985 | 2015 | 0.8 | 0.4 | 1.2 | * | |
Leukemia | C91–C95 | 0 | 1985 | 2015 | 0.3 | −0.2 | 0.8 |
ICD-10, International Classification of Diseases, 10th revision.
aYamagata, Fukui, and Nagasaki Prefectures.
*Annual % change was statistically significantly different from zero (P < 0.05).